VistaGen Therapeutics Receives $1,000,000 New Financing

  • Feed Type
  • Date
    12/22/2008
  • Company Name
    VistaGen Therapeutics
  • Mailing Address
    384 Oyster Point Blvd South San Francisco, CA 94080
  • Company Description
    VistaGen Therapeutics is a biopharmaceutical company pioneering the use of embryonic stem cells (ES cells) for drug discovery and development and predictive toxicology.
  • Website
    http://www.vistagen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed